The central government has made an advance payment of Rs 1700 crore to the Serum Institute of India for purchasing 11 crore additional doses of Covishield and Covaxin vaccine. While an advance of Rs 787.50 crore has been given for 5 crore doses of covaxine. In total, this amount is 2520 crores. The Union Ministry of Health (Health Ministry) has given this information. These 11 million doses of Kovishield vaccine will be available from the Serum Institute during May, June and July. For this, serum was released on April 28 as an advance of Rs 1732.50 crore, ie 100 percent of the total expenditure.
The center said that after deducting TDS, this amount was Rs 1699.50 crore, which was received by the serum only on April 28. The central government said that in order of previous order for 10 crore doses of Kovishield vaccine, 8.744 crore doses have been received till May 3. The Union Health Ministry has termed the media reports as incorrect and baseless, stating that the Center has not given any new orders for anti-corona vaccines.
The Health Ministry clarified that in addition, 100 percent advance of Rs 787.50 crore (Rs 772.50 crore after deducting TDS) was issued to Bharat Biotech India for five crore doses of Covaxine vaccine during May, June and July. . The same amount was received by the vaccine manufacturer on the same day. In the order of the previous order of two million doses of covaxine vaccine, more than 88 lakh doses have been received till May 3. It is wrong to say that the Central Government has not given any new order.
Till May 2, the Center has provided 16.54 crore doses of the vaccine and free of charge to the states and union territories. States still have more than 78 lakh doses. States and UTs will get more than 56 lakh doses in the next three days. Under the national Kovid-19 vaccination strategy and liberal pricing policy, the central government will continue to purchase 50 percent of the vaccines every month and make them available to the state governments completely free of cost as before.